F. Mornex

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

Bruno Chauffert, F. Mornex, F. Bonnetain et al. · Annals of Oncology · 2008 · 694 citations

Medicine, Oncology, Radiation Oncology +15

Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901

C. Mariette, Laëtitia Dahan, F. Mornex et al. · Journal of Clinical Oncology · 2014 · 605 citations

Medicine, Oncology, Surgery +17

Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study

P. Fournel, G. Robinet, P. Thomas et al. · Journal of Clinical Oncology · 2005 · 546 citations

Medicine, Oncology, Radiation Oncology +13

Late effects toxicity scoring: the SOMA scale

J.J. Pavy, J. Denekamp, J.G.J. Letschert et al. · Radiotherapy and Oncology · 1995 · 392 citations

Pharmacy, Pharmacology, Toxicology +12

Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial

D. Peiffert, L. Tournier-Rangeard, Jean‐Pierre Gérard et al. · Journal of Clinical Oncology · 2012 · 376 citations · Full text

Medicine, Oncology, Radiation Oncology +11